From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

EARLY RESPONSE TO FLUOXETINE PREDICTS LATER OUTCOME.

When a patient with major depression fails to improve after several weeks of a standard dose of fluoxetine, how likely is a response later? To shed light on this question, researchers at Massachusetts General Hospital treated 143 depressed patients with 20 mg of fluoxetine for 8 weeks and assessed each patient's response at 2-week intervals. Overall, 57 percent of patients had a good response (i.e., a 50 percent or greater decrease in score on the Hamilton Depression Rating Scale) after the full 8 weeks of treatment. Of 66 patients who had no improvement at 2 weeks, 36 percent had a good response at 8 weeks. Of 37 patients who had not responded at 4 weeks, only 19 percent had a good response at 8 weeks. Finally, 31 patients still had no response at 6 weeks, and only 7 percent of these patients achieved a good response by week 8. Comment: According to these results, the vast majority of patients destined to respond to 20 mg of fluoxetine will do so during the first month of therapy. The authors suggest that clinicians consider changing the regimen (e.g., increasing the dose, or adding or substituting another drug) when a patient with major depression has not responded after four weeks of fluoxetine treatment.

— AS Brett

Published in Journal Watch General Medicine October 24, 1995

Citation(s):

Nierenberg AA et al. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome. Am J Psychiatry 1995 Oct 152 1500-1503.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 1995. Massachusetts Medical Society. All rights reserved.